rxstat › Shortages › Doxycycline
Doxycycline shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Doxycycline products are in shortage in Canada (1 of 7 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jul 10, 2026.
In shortage since
Jun 23, 2026
Est. full return
Jul 10, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageAPO-DOXYCYCLINE MR
40MG · CAPSULE (IMMEDIATE AND DELAYED RELEASE) · APOTEX INC
DIN 02512645 · since Jun 23, 2026, est. end Jul 10, 2026 · Disruption of the manufacture of the drug.
ResolvedTEVA-DOXYCYCLINE
100MG · TABLET · TEVA CANADA LIMITED
DIN 02158574 · ended Apr 22, 2026 · Disruption of the manufacture of the drug.
ResolvedAPO-DOXY TABS 100MG
100MG · TABLET · APOTEX INC
DIN 00874256 · ended Jan 22, 2026 · Disruption of the manufacture of the drug.
ResolvedAPO-DOXY CAP 100MG
100MG · CAPSULE · APOTEX INC
DIN 00740713 · ended Mar 2, 2026 · Disruption of the manufacture of the drug.
ResolvedAPO-DOXYCYCLINE MR
40MG · CAPSULE (IMMEDIATE AND DELAYED RELEASE) · APOTEX INC
DIN 02512645 · ended Oct 30, 2025 · Disruption of the manufacture of the drug.
ResolvedTEVA-DOXYCYCLINE
100MG · CAPSULE · TEVA CANADA LIMITED
DIN 00725250 · ended Oct 14, 2025 · Disruption of the manufacture of the drug.
ResolvedAPO-DOXY CAP 100MG
100MG · CAPSULE · APOTEX INC
DIN 00740713 · ended Sep 25, 2025 · Disruption of the manufacture of the drug.
ResolvedTEVA-DOXYCYCLINE
100MG · TABLET · TEVA CANADA LIMITED
DIN 02158574 · ended Aug 7, 2025 · Disruption of the manufacture of the drug.
ResolvedAPO-DOXY TABS 100MG
100MG · TABLET · APOTEX INC
DIN 00874256 · ended Jun 13, 2025 · Disruption of the manufacture of the drug.
ResolvedTEVA-DOXYCYCLINE
100MG · CAPSULE · TEVA CANADA LIMITED
DIN 00725250 · ended Mar 19, 2025 · Disruption of the manufacture of the drug.
ResolvedAPO-DOXY CAP 100MG
100MG · CAPSULE · APOTEX INC
DIN 00740713 · ended Jun 20, 2024 · Disruption of the manufacture of the drug.
ResolvedTEVA-DOXYCYCLINE
100MG · TABLET · TEVA CANADA LIMITED
DIN 02158574 · ended Jun 18, 2024 · Disruption of the manufacture of the drug.
Showing 12 of 42 reports. All reports are on file with Health Canada.
What's happening
Doxycycline is currently affected by an active shortage report filed with Health Canada by APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Doxycycline is classified under “TETRACYCLINES” (ATC J01AA).
Recent changes
Common questions
When will Doxycycline be back in stock in Canada?
The latest manufacturer estimate is Jul 10, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Doxycycline in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.